Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments
NonrulemakingNoticeFDA-2026-N-3499-0001
Comments
0
Awaiting comments
Deadline
10 days
Closes Jul 1, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- May 1, 2026
- Comment period
- May 1, 2026 – Jul 1, 2026
- Agency
- Food and Drug Administration (FDA)
- FR Doc
- 2026-08521
Analysis
Overview
No comments yet — comment period open · 10 days left.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.